| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Chief Operating Officer
1 company
Deschatelets Pascal is a Chief Scientific Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $48.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 22, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 3,913 | $65.00 | $254,329.35 | -0.3% | -27.2% | -54.0% | |
| Jan 16, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 1,632 | $66.81 | $109,031.64 | -0.1% | -22.3% | -56.2% | |
| Nov 8, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 12,000 | $47.27 | $567,240.00 | -1.1% | +43.2% | -38.8% | |
| Oct 9, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 12,000 | $40.38 | $484,560.00 | -1.1% | +60.1% | -35.8% | |
| Sep 8, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 12,000 | $42.87 | $514,440.00 | -1.1% | +54.0% | -1.3% | |
| Aug 8, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 12,000 | $23.66 | $283,920.00 | -1.1% | +88.5% | +39.3% | |
| Jul 10, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 12,000 | $84.55 | $1,014,600.00 | -1.1% | -50.7% | -56.7% | |
| Jun 8, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 12,000 | $91.35 | $1,096,200.00 | -1.1% | -52.6% | -55.2% | |
| May 8, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 12,000 | $92.39 | $1,108,680.00 | -1.1% | -74.1% | -52.0% | |
| Apr 10, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 12,000 | $78.21 | $938,520.00 | -1.2% | +9.8% | -30.1% |